Paper42889489PubMed
Comparison of brain-derived versus conventional pTau biomarkers in CSF and plasma for detecting Alzheimer's disease.
Trudel L and 18 others. Brain Commun, 2026.
Cite this record
ConductScience Library. Comparison of brain-derived versus conventional pTau biomarkers in CSF and plasma for detecting Alzheimer's disease. Papers, record 42889489. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42889489
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of brain-derived versus conventional pTau biomarkers in CSF and plasma for detecting Alzheimer's disease.
- Journal
- Brain Commun
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-19
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40539416 | Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks. | Ann Neurol | 2025 | https://conductscience.org/library/papers/40539416 | PubMed |
| 2 | 20399250 | The influence of cerebrospinal fluid turnover on age-related changes in cerebrospinal fluid protein concentrations. | Neurosci Lett | 2010 | https://conductscience.org/library/papers/20399250 | PubMed |
| 3 | 40986433 | Implication for Clinical Trials From Longitudinal Tau-PET Accumulation Across Biological Alzheimer Disease Stages. | Neurology | 2025 | https://conductscience.org/library/papers/40986433 | PubMed |
| 4 | 33354617 | Pre-analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF. | Alzheimers Dement (Amst) | 2020 | https://conductscience.org/library/papers/33354617 | PubMed |
| 5 | 38429551 | Biomarker-based staging of Alzheimer disease: rationale and clinical applications. | Nat Rev Neurol | 2024 | https://conductscience.org/library/papers/38429551 | PubMed |
| 6 | 38575616 | Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease. | Nat Commun | 2024 | https://conductscience.org/library/papers/38575616 | PubMed |
| 7 | 37945559 | NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing. | Nat Commun | 2023 | https://conductscience.org/library/papers/37945559 | PubMed |
| 8 | 41556545 | Clinical-biological Alzheimer's disease stage concordance: insights from cohorts and autopsy data. | Brain | 2026 | https://conductscience.org/library/papers/41556545 | PubMed |
| 9 | 39394841 | Head-to-head comparison of leading blood tests for Alzheimer's disease pathology. | Alzheimers Dement | 2024 | https://conductscience.org/library/papers/39394841 | PubMed |
| 10 | 40044663 | Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosis. | Nat Commun | 2025 | https://conductscience.org/library/papers/40044663 | PubMed |
| 11 | 40388185 | Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease. | JAMA Neurol | 2025 | https://conductscience.org/library/papers/40388185 | PubMed |
| 12 | 38252443 | Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology. | JAMA Neurol | 2024 | https://conductscience.org/library/papers/38252443 | PubMed |
| 13 | 29940161 | The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review. | Alzheimers Dement | 2018 | https://conductscience.org/library/papers/29940161 | PubMed |
| 14 | 37653254 | A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases. | Nat Aging | 2023 | https://conductscience.org/library/papers/37653254 | PubMed |
| 15 | 32333900 | Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. | Lancet Neurol | 2020 | https://conductscience.org/library/papers/32333900 | PubMed |
| 16 | 40818474 | Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. | Lancet Neurol | 2025 | https://conductscience.org/library/papers/40818474 | PubMed |
| 17 | 40289884 | A comparison of p-tau assays for the specificity to detect tau changes in Alzheimer's disease. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/40289884 | PubMed |
| 18 | 33283854 | CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease. | Brain | 2021 | https://conductscience.org/library/papers/33283854 | PubMed |
| 19 | 36508198 | Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography. | JAMA Neurol | 2023 | https://conductscience.org/library/papers/36508198 | PubMed |
| 20 | 40951978 | Rates of clinical progression according to biological Alzheimer's disease stages. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/40951978 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42889489
GET https://conductscience.org/api/papers/v1/42889489/references?page=2